US EditionJohnson & Johnson reports novel tuberculosis treatment - BioPatrika
Summary by biopatrika.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Johnson & Johnson reports novel tuberculosis treatment - BioPatrika
🌍 Exciting News – Latest Tuberculosis Treatment Discovery Published in Nature! Latest Tuberculosis treatment research has just been published in Nature! Johnson & Johnson report the discovery of JNJ-6640, a novel small-molecule inhibitor that targets de novo purine biosynthesis in Mycobacterium tuberculosis — a breakthrough that could reshape the global fight against tuberculosis (TB). Citation: […] The post Johnson & Johnson reports novel tube…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
